BDSX peer analysis
Biodesix (BDSX) against its competitors: price, today's move, 1-year return and market value side by side.
BDSX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALGS Aligos Therapeutics | $4.51 | -10.16% | -38.47% | – |
| INMB INmune Bio | $1.18 | -11.65% | -33.62% | $32.85M |
| OKUR OnKure Therapeutics | $2.52 | -2.51% | -15.83% | – |
| PDSB PDS Biotechnology | $1.23 | 4.70% | 35.36% | $128.63M |
| SKYE Skye Bioscience | $1.04 | -8.77% | -91.39% | – |
| VNRX VolitionRx | $0.19 | -6.94% | -97.81% | $3.54M |
| XLO Xilio Therapeutics | $8.50 | -2.41% | -25.54% | – |
| BDSX Biodesix | $9.00 | -54.64% | 4.65% | – |
- BDSX's peers: ALGS (Aligos Therapeutics), INMB (INmune Bio), OKUR (OnKure Therapeutics), PDSB (PDS Biotechnology), SKYE (Skye Bioscience), VNRX (VolitionRx), XLO (Xilio Therapeutics).
Updated 2026-11-07 11:55 UTC